Risperidone long-acting injection in the treatment of schizophrenia: 24-month results from the…
Oral antipsychotic therapy has been characterized by nonadherence and partial adherence in patients with schizophrenia. The electronic Schizophrenia Treatment Adherence Registry (e-STAR) aimed at assessing outcomes of Risperidone…